Assessment of Prevalence of Depression among Cancer Patients Undergoing Chemotherapy Using BDI and PHQ-9 Questionnaire.

JAMIA HAMDARD0 个研究点目标入组 20 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•History of major depression
•Meet the DSM-IV criteria for a major depressive episode.
•Meet criteria for treatment resistant depression defined by failure to, respond to, or intolerance of, at least 2 treatments of antidepressants
•Active suicidal ideation
•History of any major operation in past 6 months excluding surgeries related to cancer treatment
•History of any significant cognitive impairment in past
•On any psychotropic medications
•Presence of any other concurrent illness(Parkinson disorder; Vascular disorders like Hypertension, Stroke; Endocrine disorders like Type II Diabetes Mellitus, Hypothyroidism; AIDS/HIV and rheumatoid arthritis)
•Using any concurrent medication like clonidine, methyldopa, isotretinoin, phenobarbital, levetiracetam, phenytoin, triptans and hormonal agents (corticosteroids, oral contraceptives, GnRH agonists and tamoxifen) or whose side effect is depression
•Suffered anxiety episodes in past
•History of Schizophrenia
•Alcoholics
•Habit of any substance of abuse
•History of significant dementia or intellectual disability
•Incompetent for interview
•Psychological, familial, sociological, or geographical conditions that do not permit treatment or medical follow-up and / or prohibit compliance with the study protocol

发起方